Wednesday, May 27, 2009

Phase 3...Whee!

It may be Wednesday but I have some words! Today the drug VX-770 that is aimed to fix the defective gene in one of Gavin's gene mutations (G551D) entered into phase THREE of clinical trials today. We have a clinic appointment tomorrow where I will ask more questions, but this has the potential to be WONDERFUL news for our little family!

Please click here for more info!

No comments:

Post a Comment